Non-Small Cell Lung Cancer
Pancreatic Cancer
Metastatic Breast Cancer
Ovarian Cancer
About GEMZAR
Resources
Important Safety Information
Prescribing Information
Text Size Print


Types of Breast Cancer

There are two kinds of breast cancer, "invasive" and "noninvasive."

Invasive Breast Cancer
Invasive breast cancer is the more serious of the two types. It happens when abnormal cells from inside the breast's lobules or ducts spread into the surrounding breast tissue. This allows the cancer to spread to the lymph nodes and, in advanced stages, to areas such as the liver, lungs, and bones.

Healthcare professionals now believe that cancer cells can spread from the breast through the blood and lymphatic system at early stages of the disease, even though these spreading cancer cells do not always survive.

A phrase that you may hear from your healthcare team is the term "locally advanced" breast cancer. This is usually referred to as cancer that has not spread to another area in the body. However, the following issues may nonetheless have occurred1:

  • The cancer in the breast may be bigger than 5 centimeters across
  • The cancer may have spread into the skin or muscle of the chest, or
  • There may be cancer in the lymph nodes under the arm

Locally advanced breast cancer can be any or all of the above. Locally advanced could mean either stage II or stage III breast cancer (see Diagnosis and Staging).

Noninvasive Breast Cancer
"In situ" means "in place" and the term "carcinoma in situ" is used to describe this condition because the cancer cells remain in their original location and do not spread, or "metastasize" to the surrounding tissue or beyond. When abnormal cells grow inside the lobules, it is called "lobular carcinoma in situ." When abnormal cells grow inside the milk ducts, it is called "ductal carcinoma in situ."1

Carcinoma in situ is thought of as a precancerous condition because it can develop into or raise your risk for a more serious, invasive cancer.1

Subtypes of Breast Cancer
Many types of breast cancer are diagnosed, and some of them are very rare. In some instances a breast tumor can be a combination of these types, and even contain a mixture of invasive and noninvasive types.2

  • Ductal carcinoma in situ (also called "DCIS")
    The most common type of noninvasive breast cancer, DCIS is found only in the ducts, and has not spread. Nearly all women with cancer at this stage can be cured. Early diagnosis is possible with a mammogram.2
  • Lobular carcinoma in situ (also called "LCIS")
    Begins in the milk-making glands but has not spread through the wall of the lobules. Although not a true cancer, having LCIS increases a woman's risk of getting cancer later. Women with LCIS should definitely screen for cancer.2
  • Invasive (infiltrating) ductal carcinoma (also called "IDC")
    The most common form of breast cancer, IDC starts in a milk passage or duct, breaks through the wall of the duct, and invades the breast tissue. From there it can spread to other parts of the body. IDC accounts for about 8 out of 10 invasive breast cancers.2
  • Invasive (infiltrating) lobular carcinoma (also called "ILC")
    Starts in the milk glands or lobules, where it can spread to other parts of the body. ILC accounts for roughly 1 out of 10 invasive breast cancers.2
  • Inflammatory breast cancer (also called "IBC")
    A rare type of invasive breast cancer that accounts for about 1% to 3% of all breast cancers. Usually there is no lump or tumor. Instead, IBC makes the skin of the breast look red and feel warm, and gives the skin a thick, pitted appearance that are not caused by inflammation or infection, but by cancer cells blocking lymph vessels in the skin. IBC is often mistaken for an infection in its early stages, and may not appear on a mammogram.2
A risk factor is something that can affect a person's chance of getting a disease such as breast cancer.2

Risk Factors
The exact cause of breast cancer remains unknown, although several risk factors have been linked to the disease. Some risk factors, such as smoking, can be controlled. Others, like a person's age, can't be changed. Having one or more risk factors does not mean that a person will get the disease.3

Now let's journey to Diagnosis and Staging.

References:

  1. National Cancer Institute. Staging. Available at:
    http://www.cancer.gov/cancertopics/wyntk/breast/page9. Accessed Arpil 14, 2008.
  2. American Cancer Society. What Is Breast Cancer? Available at:
    http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_What_is_breast_cancer_5.asp.
    Accessed March 3, 2008.
  3. American Cancer Society. What Are the Risk Factors for Breast Cancer? Available at:
    http://www.cancer.org/docroot/CRI/content/….
    Accessed March 3, 2008.


About GEMZAR

GEMZAR is indicated in combination with cisplatin (another type of chemotherapy) for the first-line treatment of patients with locally advanced (stage IIIA or stage IIIB) or metastatic (stage IV or cancer that has spread) non-small cell lung cancer for whom surgery is not possible.

GEMZAR is indicated in combination with carboplatin (another type of chemotherapy) for the woman with ovarian cancer that has returned at least 6 months after the patient had finished platinum-based therapy.

GEMZAR in combination with paclitaxel is approved by the FDA for the first-line treatment of patients with metastatic breast cancer after they have received another type of chemotherapy called an anthracycline, unless their medical condition did not allow them to receive an anthracycline.

GEMZAR is indicated as a single agent (given alone) as the first-line treatment for patients with locally advanced (stage II or stage III when surgery is not an option) or metastatic (stage IV) adenocarcinoma of the pancreas. GEMZAR is also indicated for patients previously treated with 5-FU (another type of chemotherapy).

Important Safety Information

GEMZAR may not be appropriate for some patients.

If you are allergic to GEMZAR, tell your doctor you should not receive it. GEMZAR can suppress bone marrow function. There have been rare reports of serious kidney or liver toxicity with GEMZAR treatment, sometimes fatal. Serious lung toxicity has also been reported, sometimes fatal. If you think you are pregnant, are planning to be pregnant, or are nursing, please tell your healthcare team. GEMZAR may harm your unborn or nursing baby.

If you have had prior kidney or liver problems or impairment, please tell your healthcare professional. GEMZAR may not be right for you. GEMZAR has not been shown to work in children. Tell your doctor if you are taking other medicines, including prescription and nonprescription medicines, vitamins, or herbal supplements.

There is a risk of side effects associated with GEMZAR therapy. The most common side effects are low blood cell counts (red blood cells, white blood cells, and platelets); fever; infection; hair loss; tiredness; nausea, vomiting, constipation, and diarrhea; rash; shortness of breath; muscle aches; and numbness or tingling in your toes or fingers. These are not all of the side effects of GEMZAR. If you have any side effect that bothers you or that doesn't go away, be sure to talk with your healthcare professional. Call your healthcare professional right away if you have fever or chills. These symptoms could mean you have an infection.

You will have regular blood tests before and during your treatment with GEMZAR. Your doctor may adjust your dose of GEMZAR or delay your treatment based on the results of your blood test and on your general condition.

For more information about all of the side effects of GEMZAR, please talk with your healthcare team, see the complete Prescribing Information, or call 1-800-545-5979.

SG22